NCT04097951View on ClinicalTrials.gov

HDDO-1801 Intervention Trial

PHASE1UnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 8, 2019

Primary Completion Date

January 8, 2020

Study Completion Date

February 28, 2020

Conditions
Respiratory Disease
Interventions
DRUG

Combinations

Montelukast and Bepotastine Combination

Trial Locations (1)

22332

Inha University Hospital, Junggu

Sponsors
All Listed Sponsors
lead

Hyundai Pharmaceutical Co., LTD.

INDUSTRY